ACROVIZ INC.
Update：2025/12/03
Industries
Main Industry
Health Care
Main Product/Service
AcroViz Technology
Analyze neuro-images to predict brain health
Decode brain health information to prolong health span
Analyze neuro-images to predict brain health
Decode brain health information to prolong health span
Founded Year
2017
Unified Business No.
55749867
Status
Active
Number of Employees
0
Total Paid-in
Capital
114,212,160 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
AcroViz develops novel imaging biomarkers for brain health, in an effort to prolong human health span with state-of-art technologies. Comprising eminent academia researchers and experienced industrial professionals, the team is devoted to advancing scientific research, maximizing its clinical significance and application, as well as commercialization to achieve extended positive impact. The first product: AcroViz Axonal Brain Age – Brain Health Report, is the first to the market that adopting diffusion Magnetic Resonance Imaging (dMRI) and Machine Learning techniques to provide accurate and objective brain health assessment, which can serve as a Mild Cognitive Impairment (MCI) marker in predicting the risk and prognosis of dementia, such as Alzheimer’s Disease (AD).
